Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies, 38969-38971 [05-13326]
Download as PDF
<![CDATA[
38969
Federal Register / Vol. 70, No. 128 / Wednesday, July 6, 2005 / Notices
ESTIMATES OF ANNUALIZED HOUR BURDEN
Responses
per
respondents
Number of
respondents
Form
Hours per
responses
Total hour
burden
Individual Crisis Counseling Services Encounter Log .....................................
Group Encounter Log Form .............................................................................
Weekly Tally Sheet ..........................................................................................
Assessment & Referral Tool ............................................................................
Participant Feedback .......................................................................................
CCP Service Provider Feedback .....................................................................
7,500
4,000
4,000
100
1,000
100
1
1
1
1
1
1
.03
.03
.08
.08
.06
.08
225
120
320
8
60
8
Total ..........................................................................................................
16,700
........................
........................
741
Written comments and
recommendations concerning the
proposed information collection should
be sent by August 5, 2005, to: SAMHSA
Desk Officer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503; due to potential delays in OMB’s
receipt and processing of mail sent
through the U.S. Postal Service,
respondents are encouraged to submit
comments by fax to: 202–395–6974.
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://workplace.samhsa.gov
and https://www.drugfreeworkplace.gov.
Dated: June 29, 2005.
Patricia S. Bransford,
Acting Executive Officer, SAMHSA.
[FR Doc. 05–13238 Filed 7–5–05; 8:45 am]
Mrs.
Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs,
SAMHSA/CSAP, Room 2–1035, 1 Choke
Cherry Road, Rockville, Maryland
20857; 240–276–2600 (voice), 240–276–
2610 (fax).
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
16:35 Jul 05, 2005
Jkt 205001
The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Pub. L. 100–
71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
SUPPLEMENTARY INFORMATION:
Substance Abuse and Mental Health
Services Administration
VerDate jul<14>2003
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227, 414–328–
7840/800–877–7016, (Formerly:
Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118, 901–794–5770/888–290–
1150.
Aegis Analytical Laboratories, Inc., 345
Hill Ave., Nashville, TN 37210, 615–
255–2400.
Baptist Medical Center—Toxicology
Laboratory, 9601 I–630, Exit 7, Little
Rock, AR 72205–7299, 501–202–2783,
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira
Road, Lenexa, KS 66215–2802, 800–
445–6917.
Diagnostic Services, Inc., dba DSI,
12700 Westlinks Drive, Fort Myers,
FL 33913, 239–561–8200/800–735–
5416.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602, 229–671–
2281.
DrugProof, Division of Dynacare/
Laboratory of Pathology, LLC, 1229
Madison St., Suite 500, Nordstrom
Medical Tower, Seattle, WA 98104,
206–386–2661/800–898–0180,
(Formerly: Laboratory of Pathology of
Seattle, Inc., DrugProof, Division of
Laboratory of Pathology of Seattle,
Inc.).
DrugScan, Inc., P.O. Box 2969, 1119
Mearns Road, Warminster, PA 18974,
215–674–9310.
Dynacare Kasper Medical Laboratories*,
10150–102 St., Suite 200, Edmonton,
Alberta, Canada T5J 5E2, 780–451–
3702/800–661–9876.
ElSohly Laboratories, Inc., 5 Industrial
Park Drive, Oxford, MS 38655, 662–
236–2609.
Express Analytical Labs, 3405 7th Ave.,
Suite 106, Marion, IA 52302, 319–
377–0500.
E:\FR\FM\06JYN1.SGM
06JYN1
38970
Federal Register / Vol. 70, No. 128 / Wednesday, July 6, 2005 / Notices
General Medical Laboratories, 36 South
Brooks St., Madison, WI 53715, 608–
267–6225.
Kroll Laboratory Specialists, Inc., 1111
Newton St., Gretna, LA 70053, 504–
361–8989/800–433–3823, (Formerly:
Laboratory Specialists, Inc.).
LabOne, Inc., 10101 Renner Blvd.,
Lenexa, KS 66219, 913–888–3927/
800–873–8845, (Formerly: Center for
Laboratory Services, a Division of
LabOne, Inc.).
Laboratory Corporation of America
Holdings, 7207 N. Gessner Road,
Houston, TX 77040, 713–856–8288/
800–800–2387.
Laboratory Corporation of America
Holdings, 69 First Ave., Raritan, NJ
08869, 908–526–2400/800–437–4986,
(Formerly: Roche Biomedical
Laboratories, Inc.).
Laboratory Corporation of America
Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709,
919–572–6900/800–833–3984,
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group).
Laboratory Corporation of America
Holdings, 10788 Roselle St., San
Diego, CA 92121, 800–882–7272,
(Formerly: Poisonlab, Inc.).
Laboratory Corporation of America
Holdings, 1120 Main Street,
Southaven, MS 38671, 866–827–8042/
800–233–6339, (Formerly: LabCorp
Occupational Testing Services, Inc.;
MedExpress/National Laboratory
Center).
Marshfield Laboratories, Forensic
Toxicology Laboratory, 1000 North
Oak Ave., Marshfield, WI 54449, 715–
389–3734/800–331–3734.
MAXXAM Analytics Inc.*, 6740
Campobello Road, Mississauga, ON,
Canada L5N 2L8, 905–817–5700,
(Formerly: NOVAMANN (Ontario),
Inc.).
MedTox Laboratories, Inc., 402 W.
County Road D, St. Paul, MN 55112,
651–636–7466/800–832–3244.
MetroLab-Legacy Laboratory Services,
1225 NE 2nd Ave., Portland, OR
97232, 503–413–5295/800–950–5295.
Minneapolis Veterans Affairs Medical
Center, Forensic Toxicology
Laboratory, 1 Veterans Drive,
Minneapolis, MN 55417, 612–725–
2088.
National Toxicology Laboratories, Inc.,
1100 California Ave., Bakersfield, CA
93304, 661–322–4250/800–350–3515.
Northwest Toxicology, a LabOne
Company, 2282 South Presidents
Drive, Suite C, West Valley City, UT
VerDate jul<14>2003
16:35 Jul 05, 2005
Jkt 205001
84120, 801–606–6301/800–322–3361,
(Formerly: LabOne, Inc., dba
Northwest Toxicology; NWT Drug
Testing, NorthWest Toxicology, Inc.;
Northwest Drug Testing, a division of
NWT Inc.).
One Source Toxicology Laboratory, Inc.,
1213 Genoa-Red Bluff, Pasadena, TX
77504, 888–747–3774, (Formerly:
University of Texas Medical Branch,
Clinical Chemistry Division; UTMB
Pathology-Toxicology Laboratory).
Oregon Medical Laboratories, P.O. Box
972, 722 East 11th Ave., Eugene, OR
97440–0972, 541–687–2134.
Pacific Toxicology Laboratories, 9348
DeSoto Ave., Chatsworth, CA 91311,
800–328–6942, (Formerly: Centinela
Hospital Airport Toxicology
Laboratory).
Pathology Associates Medical
Laboratories, 110 West Cliff Dr.,
Spokane, WA 99204, 509–755–8991/
800–541–7897x7.
Physicians Reference Laboratory, 7800
West 110th St., Overland Park, KS
66210, 913–339–0372/800–821–3627.
Quest Diagnostics Incorporated, 3175
Presidential Dr., Atlanta, GA 30340,
770–452–1590/800–729–6432,
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated, 4770
Regent Blvd., Irving, TX 75063, 800–
824–6152, (Moved from the Dallas
location on 03/31/01; Formerly:
SmithKline Beecham Clinical
Laboratories; SmithKline Bio-Science
Laboratories).
Quest Diagnostics Incorporated, 4230
South Burnham Ave., Suite 250, Las
Vegas, NV 89119–5412, 702–733–
7866/800–433–2750, (Formerly:
Associated Pathologists Laboratories,
Inc.).
Quest Diagnostics Incorporated, 400
Egypt Road, Norristown, PA 19403,
610–631–4600/877–642–2216,
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated, 506 E.
State Pkwy., Schaumburg, IL 60173,
800–669–6995/847–885–2010,
(Formerly: SmithKline Beecham
Clinical Laboratories; International
Toxicology Laboratories).
Quest Diagnostics Incorporated, 7600
Tyrone Ave., Van Nuys, CA 91405,
818–989–2520/800–877–2520,
(Formerly: SmithKline Beecham
Clinical Laboratories).
Scientific Testing Laboratories, Inc., 450
Southlake Blvd., Richmond, VA
23236, 804–378–9130.
Sciteck Clinical Laboratories, Inc., 317
Rutledge Road, Fletcher, NC 28732,
828–650–0409.
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
S.E.D. Medical Laboratories, 5601 Office
Blvd., Albuquerque, NM 87109, 505–
727–6300/800–999–5227.
South Bend Medical Foundation, Inc.,
530 N. Lafayette Blvd., South Bend,
IN 46601, 574–234–4176x276.
Southwest Laboratories, 4645 E. Cotton
Center Boulevard, Suite 177, Phoenix,
AZ 85040, 602–438–8507/800–279–
0027.
Sparrow Health System, Toxicology
Testing Center, St. Lawrence Campus,
1210 W. Saginaw, Lansing, MI 48915,
517–364–7400, (Formerly: St.
Lawrence Hospital & Healthcare
System).
St. Anthony Hospital Toxicology
Laboratory, 1000 N. Lee St.,
Oklahoma City, OK 73101, 405–272–
7052.
Toxicology & Drug Monitoring
Laboratory, University of Missouri
Hospital & Clinics, 301 Business Loop
70 West, Suite 208, Columbia, MO
65203, 573–882–1273.
Toxicology Testing Service, Inc., 5426
NW. 79th Ave., Miami, FL 33166,
305–593–2260.
U.S. Army Forensic Toxicology Drug
Testing Laboratory, 2490 Wilson St.,
Fort George G. Meade, MD 20755–
5235, 301–677–7085.
*The Standards Council of Canada
(SCC) voted to end its Laboratory
Accreditation Program for Substance
Abuse (LAPSA) effective May 12, 1998.
Laboratories certified through that
program were accredited to conduct
forensic urine drug testing as required
by U.S. Department of Transportation
(DOT) regulations. As of that date, the
certification of those accredited
Canadian laboratories will continue
under DOT authority. The responsibility
for conducting quarterly performance
testing plus periodic on-site inspections
of those LAPSA-accredited laboratories
was transferred to the U.S. HHS, with
the HHS’ NLCP contractor continuing to
have an active role in the performance
testing and laboratory inspection
processes. Other Canadian laboratories
wishing to be considered for the NLCP
may apply directly to the NLCP
contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to
be qualified, HHS will recommend that
DOT certify the laboratory (Federal
Register, July 16, 1996) as meeting the
minimum standards of the Mandatory
Guidelines published in the Federal
Register on April 13, 2004 (69 FR
19644). After receiving DOT
certification, the laboratory will be
included in the monthly list of HHScertified laboratories and participate in
E:\FR\FM\06JYN1.SGM
06JYN1
Federal Register / Vol. 70, No. 128 / Wednesday, July 6, 2005 / Notices
the NLCP certification maintenance
program.
Pat Bransford,
Acting Executive Officer, SAMHSA.
[FR Doc. 05–13326 Filed 7–5–05; 8:45 am]
BILLING CODE 4160–20–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–4837–D–58]
Revocation and Redelegation of Fair
Housing Act Complaint Processing
Authority
Office of the Assistant
Secretary for Fair Housing and Equal
Opportunity, HUD.
ACTION: Notice of revocation and
redelegation of authority.
AGENCY:
SUMMARY: The General Deputy Assistant
Secretary for Fair Housing and Equal
Opportunity (FHEO) revokes the prior
redelegation of his authority for Fair
Housing Act complaint processing,
made on August 4, 2003 (68 FR 45846),
and redelegates complaint processing
authority to FHEO field and
headquarters staff.
EFFECTIVE DATE: June 23, 2005.
FOR FURTHER INFORMATION CONTACT:
Karen A. Newton, Deputy Assistant
Secretary for Operations and
Management, Office of Fair Housing and
Equal Opportunity, Department of
Housing and Urban Development, 451
Seventh Street SW., Room 5128,
Washington, DC 20410–0001, telephone
(202) 708–0768. (This is not a toll-free
number.) Hearing- and speech-impaired
individuals may access this number
through TTY by calling the toll-free
Federal Information Relay Service at
(800) 877–8339.
SUPPLEMENTARY INFORMATION: In a March
30, 1989, notice (54 FR 13121), the
Secretary of HUD delegated the
authority to enforce the Fair Housing
Act to the Assistant Secretary for FHEO
and the General Counsel. On August 4,
2003 (68 FR 45846), the Assistant
Secretary for FHEO revoked all prior
redelegations of authority for complaint
processing under the Fair Housing Act
(42 U.S.C. 3601 et seq.) and redelegated
that authority to the General Deputy
Assistant Secretary for Fair Housing and
Equal Opportunity. The General Deputy
Assistant Secretary then further
redelegated that complaint processing
authority to field and headquarters staff.
After the August 4, 2003 redelegations,
the FHEO Hub Directors’ titles were
changed to FHEO Region Directors.
Additionally the Young Implementation
VerDate jul<14>2003
16:35 Jul 05, 2005
Jkt 205001
Office closed and, consequently, there is
no longer a need for delegations of
authority to the Young Implementation
Office. Additionally, effective January
23, 2005, FHEO created an Office of
Systemic Investigations.
The Assistant Secretary’s August 4,
2003 redelegation of authority for
complaint processing under the Fair
Housing Act to the General Deputy
Assistant Secretary for FHEO remains
intact. However, the General Deputy
Assistant Secretary revokes the
redelegations of Fair Housing Act
complaint processing authority issued
by him on August 4, 2003, and
redelegates that authority as provided in
this notice.
Section A. Authority Redelegated
The General Deputy Assistant
Secretary for FHEO retains and
redelegates the Fair Housing Act
complaint processing authority under
24 CFR part 103 to the Deputy Assistant
Secretary for Enforcement and
Programs.
The Deputy Assistant Secretary for
Enforcement and Programs retains and
further redelegates the Fair Housing Act
complaint processing under 24 CFR part
103, subparts A, B, C, D (with the
exception of the filing of a Secretaryinitiated complaint under 24 CFR
103.204(a)), E, and F, to the FHEO
Region Directors, the FHEO Director of
the Office of Enforcement, and the
FHEO Director of the Office of Systemic
Investigations.
The Deputy Assistant Secretary for
Enforcement and Programs for FHEO
retains and further redelegates the
authority under 24 CFR 103.510(a) and
(d) of 24 CFR subpart H to the FHEO
Region Directors, the Director of the
Office of Enforcement, and the Director
of the Office of Systemic Investigations,
with the exception of pattern and
practice referrals to the Attorney
General, which are redelegated only to
the Director of the Office of
Enforcement, and the Director of the
Office of Systemic Investigations.
The Deputy Assistant Secretary for
Enforcement and Programs for FHEO
retains and further redelegates the
authority to reconsider no cause
determinations (issued pursuant to 24
CFR 103.400(a)(2)(ii)) to the Director of
the Office of Enforcement.
Office of Systemic Investigations may
not redelegate the authorities provided
in Section A of this notice.
Section C. Authority Revoked
The August 4, 2003, redelegation of
the General Deputy Assistant Secretary’s
authority (68 FR 45846) is revoked.
Authority: Section 7(d) of the Department
of Housing and Urban Development Act (42
U.S.C. 3535(d)).
Dated: June 23, 2005.
Floyd O. May,
General Deputy, Assistant Secretary for Fair
Housing and Equal Opportunity.
[FR Doc. E5–3499 Filed 7–5–05; 8:45 am]
BILLING CODE 4210–27–P
Section B. Authority To Further
Redelegate
The Deputy Assistant Secretary for
Enforcement and Programs may
redelegate the authorities provided in
Section A of this notice. The Director of
the Office of Enforcement, the FHEO
Region Directors, and the Director of the
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
38971
E:\FR\FM\06JYN1.SGM
06JYN1
]]>Agencies
[Federal Register Volume 70, Number 128 (Wednesday, July 6, 2005)]
[Notices]
[Pages 38969-38971]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-13326]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Current List of Laboratories Which Meet Minimum Standards To
Engage in Urine Drug Testing for Federal Agencies
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) notifies
Federal agencies of the laboratories currently certified to meet the
standards of Subpart C of the Mandatory Guidelines for Federal
Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory
Guidelines were first published in the Federal Register on April 11,
1988 (53 FR 11970), and subsequently revised in the Federal Register on
June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on
April 13, 2004 (69 FR 19644).
A notice listing all currently certified laboratories is published
in the Federal Register during the first week of each month. If any
laboratory's certification is suspended or revoked, the laboratory will
be omitted from subsequent lists until such time as it is restored to
full certification under the Mandatory Guidelines.
If any laboratory has withdrawn from the HHS National Laboratory
Certification Program (NLCP) during the past month, it will be listed
at the end, and will be omitted from the monthly listing thereafter.
This notice is also available on the Internet at https://
workplace.samhsa.gov and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs, SAMHSA/CSAP, Room 2-1035, 1 Choke
Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-
2610 (fax).
SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in
accordance with Executive Order 12564 and section 503 of Pub. L. 100-
71. Subpart C of the Mandatory Guidelines, ``Certification of
Laboratories Engaged in Urine Drug Testing for Federal Agencies,'' sets
strict standards that laboratories must meet in order to conduct drug
and specimen validity tests on urine specimens for Federal agencies. To
become certified, an applicant laboratory must undergo three rounds of
performance testing plus an on-site inspection. To maintain that
certification, a laboratory must participate in a quarterly performance
testing program plus undergo periodic, on-site inspections.
Laboratories which claim to be in the applicant stage of
certification are not to be considered as meeting the minimum
requirements described in the HHS Mandatory Guidelines. A laboratory
must have its letter of certification from HHS/SAMHSA (formerly: HHS/
NIDA) which attests that it has met minimum standards.
In accordance with Subpart C of the Mandatory Guidelines dated
April 13, 2004 (69 FR 19644), the following laboratories meet the
minimum standards to conduct drug and specimen validity tests on urine
specimens:
ACL Laboratories, 8901 W. Lincoln Ave., West Allis, WI 53227, 414-328-
7840/800-877-7016, (Formerly: Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624,
585-429-2264.
Advanced Toxicology Network, 3560 Air Center Cove, Suite 101, Memphis,
TN 38118, 901-794-5770/888-290-1150.
Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN
37210, 615-255-2400.
Baptist Medical Center--Toxicology Laboratory, 9601 I-630, Exit 7,
Little Rock, AR 72205-7299, 501-202-2783, (Formerly: Forensic
Toxicology Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802, 800-
445-6917.
Diagnostic Services, Inc., dba DSI, 12700 Westlinks Drive, Fort Myers,
FL 33913, 239-561-8200/800-735-5416.
Doctors Laboratory, Inc., 2906 Julia Drive, Valdosta, GA 31602, 229-
671-2281.
DrugProof, Division of Dynacare/Laboratory of Pathology, LLC, 1229
Madison St., Suite 500, Nordstrom Medical Tower, Seattle, WA 98104,
206-386-2661/800-898-0180, (Formerly: Laboratory of Pathology of
Seattle, Inc., DrugProof, Division of Laboratory of Pathology of
Seattle, Inc.).
DrugScan, Inc., P.O. Box 2969, 1119 Mearns Road, Warminster, PA 18974,
215-674-9310.
Dynacare Kasper Medical Laboratories*, 10150-102 St., Suite 200,
Edmonton, Alberta, Canada T5J 5E2, 780-451-3702/800-661-9876.
ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655,
662-236-2609.
Express Analytical Labs, 3405 7th Ave., Suite 106, Marion, IA 52302,
319-377-0500.
[[Page 38970]]
General Medical Laboratories, 36 South Brooks St., Madison, WI 53715,
608-267-6225.
Kroll Laboratory Specialists, Inc., 1111 Newton St., Gretna, LA 70053,
504-361-8989/800-433-3823, (Formerly: Laboratory Specialists, Inc.).
LabOne, Inc., 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-
873-8845, (Formerly: Center for Laboratory Services, a Division of
LabOne, Inc.).
Laboratory Corporation of America Holdings, 7207 N. Gessner Road,
Houston, TX 77040, 713-856-8288/800-800-2387.
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ
08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical
Laboratories, Inc.).
Laboratory Corporation of America Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly:
LabCorp Occupational Testing Services, Inc., CompuChem Laboratories,
Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical
Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche
Group).
Laboratory Corporation of America Holdings, 10788 Roselle St., San
Diego, CA 92121, 800-882-7272, (Formerly: Poisonlab, Inc.).
Laboratory Corporation of America Holdings, 1120 Main Street,
Southaven, MS 38671, 866-827-8042/800-233-6339, (Formerly: LabCorp
Occupational Testing Services, Inc.; MedExpress/National Laboratory
Center).
Marshfield Laboratories, Forensic Toxicology Laboratory, 1000 North Oak
Ave., Marshfield, WI 54449, 715-389-3734/800-331-3734.
MAXXAM Analytics Inc.*, 6740 Campobello Road, Mississauga, ON, Canada
L5N 2L8, 905-817-5700, (Formerly: NOVAMANN (Ontario), Inc.).
MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112,
651-636-7466/800-832-3244.
MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR
97232, 503-413-5295/800-950-5295.
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088.
National Toxicology Laboratories, Inc., 1100 California Ave.,
Bakersfield, CA 93304, 661-322-4250/800-350-3515.
Northwest Toxicology, a LabOne Company, 2282 South Presidents Drive,
Suite C, West Valley City, UT 84120, 801-606-6301/800-322-3361,
(Formerly: LabOne, Inc., dba Northwest Toxicology; NWT Drug Testing,
NorthWest Toxicology, Inc.; Northwest Drug Testing, a division of NWT
Inc.).
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena,
TX 77504, 888-747-3774, (Formerly: University of Texas Medical Branch,
Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory).
Oregon Medical Laboratories, P.O. Box 972, 722 East 11th Ave., Eugene,
OR 97440-0972, 541-687-2134.
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA
91311, 800-328-6942, (Formerly: Centinela Hospital Airport Toxicology
Laboratory).
Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane,
WA 99204, 509-755-8991/800-541-7897x7.
Physicians Reference Laboratory, 7800 West 110th St., Overland Park, KS
66210, 913-339-0372/800-821-3627.
Quest Diagnostics Incorporated, 3175 Presidential Dr., Atlanta, GA
30340, 770-452-1590/800-729-6432, (Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 4770 Regent Blvd., Irving, TX 75063,
800-824-6152, (Moved from the Dallas location on 03/31/01; Formerly:
SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science
Laboratories).
Quest Diagnostics Incorporated, 4230 South Burnham Ave., Suite 250, Las
Vegas, NV 89119-5412, 702-733-7866/800-433-2750, (Formerly: Associated
Pathologists Laboratories, Inc.).
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403,
610-631-4600/877-642-2216, (Formerly: SmithKline Beecham Clinical
Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 506 E. State Pkwy., Schaumburg, IL
60173, 800-669-6995/847-885-2010, (Formerly: SmithKline Beecham
Clinical Laboratories; International Toxicology Laboratories).
Quest Diagnostics Incorporated, 7600 Tyrone Ave., Van Nuys, CA 91405,
818-989-2520/800-877-2520, (Formerly: SmithKline Beecham Clinical
Laboratories).
Scientific Testing Laboratories, Inc., 450 Southlake Blvd., Richmond,
VA 23236, 804-378-9130.
Sciteck Clinical Laboratories, Inc., 317 Rutledge Road, Fletcher, NC
28732, 828-650-0409.
S.E.D. Medical Laboratories, 5601 Office Blvd., Albuquerque, NM 87109,
505-727-6300/800-999-5227.
South Bend Medical Foundation, Inc., 530 N. Lafayette Blvd., South
Bend, IN 46601, 574-234-4176x276.
Southwest Laboratories, 4645 E. Cotton Center Boulevard, Suite 177,
Phoenix, AZ 85040, 602-438-8507/800-279-0027.
Sparrow Health System, Toxicology Testing Center, St. Lawrence Campus,
1210 W. Saginaw, Lansing, MI 48915, 517-364-7400, (Formerly: St.
Lawrence Hospital & Healthcare System).
St. Anthony Hospital Toxicology Laboratory, 1000 N. Lee St., Oklahoma
City, OK 73101, 405-272-7052.
Toxicology & Drug Monitoring Laboratory, University of Missouri
Hospital & Clinics, 301 Business Loop 70 West, Suite 208, Columbia, MO
65203, 573-882-1273.
Toxicology Testing Service, Inc., 5426 NW. 79th Ave., Miami, FL 33166,
305-593-2260.
U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St.,
Fort George G. Meade, MD 20755-5235, 301-677-7085.
*The Standards Council of Canada (SCC) voted to end its Laboratory
Accreditation Program for Substance Abuse (LAPSA) effective May 12,
1998. Laboratories certified through that program were accredited to
conduct forensic urine drug testing as required by U.S. Department of
Transportation (DOT) regulations. As of that date, the certification of
those accredited Canadian laboratories will continue under DOT
authority. The responsibility for conducting quarterly performance
testing plus periodic on-site inspections of those LAPSA-accredited
laboratories was transferred to the U.S. HHS, with the HHS' NLCP
contractor continuing to have an active role in the performance testing
and laboratory inspection processes. Other Canadian laboratories
wishing to be considered for the NLCP may apply directly to the NLCP
contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to be qualified, HHS will
recommend that DOT certify the laboratory (Federal Register, July 16,
1996) as meeting the minimum standards of the Mandatory Guidelines
published in the Federal Register on April 13, 2004 (69 FR 19644).
After receiving DOT certification, the laboratory will be included in
the monthly list of HHS-certified laboratories and participate in
[[Page 38971]]
the NLCP certification maintenance program.
Pat Bransford,
Acting Executive Officer, SAMHSA.
[FR Doc. 05-13326 Filed 7-5-05; 8:45 am]
BILLING CODE 4160-20-P
